TIANHONG ASSET MANTIANHONG ASSET MANTIANHONG ASSET MAN

TIANHONG ASSET MAN

No trades
See on Supercharts

About TIANHONG ASSET MAN


Issuer
Ant Group Co., Ltd.
Brand
Tianhong
Expense ratio
0.60%
Home page
Inception date
Jun 24, 2021
Index tracked
National Securities Biomedical Index - CNY - Benchmark TR Gross
Management style
Passive
ISIN
CNE100004JQ4
Tightly track the target index, and pursue the minimization of tracking deviation and tracking err

Classification


Asset Class
Equity
Category
Sector
Focus
Health care
Niche
Biotechnology
Strategy
Vanilla
Weighting scheme
Market cap
Selection criteria
Market cap

Returns


1 month3 monthsYear to date1 year3 years5 years
Price performance
NAV total return

What's in the fund


As of June 30, 2024
Exposure type
StocksBonds, Cash & Other
Health Technology
Stocks99.28%
Health Technology82.74%
Commercial Services9.65%
Process Industries6.89%
Bonds, Cash & Other0.72%
Cash0.72%
Stock breakdown by region
100%
Asia100.00%
North America0.00%
Latin America0.00%
Europe0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings

Dividends


Dividend payout history

Assets under management (AUM)



Fund Flows